Raia Drogasil S.A.
RADLY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $11,265 | $10,831 | $10,051 | $10,088 |
| % Growth | 4% | 7.8% | -0.4% | – |
| Cost of Goods Sold | $8,458 | $7,630 | $7,168 | $7,100 |
| Gross Profit | $2,807 | $3,201 | $2,883 | $2,988 |
| % Margin | 24.9% | 29.6% | 28.7% | 29.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $373 | $378 | $432 |
| SG&A Expenses | $2,074 | $2,482 | $2,409 | $2,462 |
| Sales & Mktg Exp. | $0 | $2,108 | $2,031 | $2,030 |
| Other Operating Expenses | -$13 | $3 | -$11 | -$5 |
| Operating Expenses | $2,061 | $2,484 | $2,398 | $2,457 |
| Operating Income | $746 | $717 | $485 | $531 |
| % Margin | 6.6% | 6.6% | 4.8% | 5.3% |
| Other Income/Exp. Net | -$202 | -$317 | -$285 | -$252 |
| Pre-Tax Income | $545 | $400 | $200 | $279 |
| Tax Expense | $83 | $17 | $35 | -$69 |
| Net Income | $454 | $374 | $164 | $348 |
| % Margin | 4% | 3.5% | 1.6% | 3.5% |
| EPS | 0.27 | 0.23 | 0.1 | 0.21 |
| % Growth | 17.4% | 130.9% | -52.6% | – |
| EPS Diluted | 0.27 | 0.23 | 0.099 | 0.21 |
| Weighted Avg Shares Out | 1,713 | 1,647 | 1,646 | 1,649 |
| Weighted Avg Shares Out Dil | 1,713 | 1,656 | 1,654 | 1,661 |
| Supplemental Information | – | – | – | – |
| Interest Income | $13 | $0 | $0 | $0 |
| Interest Expense | $273 | $279 | $217 | $214 |
| Depreciation & Amortization | $508 | $504 | $497 | -$475 |
| EBITDA | $1,325 | $1,183 | $915 | $11 |
| % Margin | 11.8% | 10.9% | 9.1% | 0.1% |